UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033622
Receipt number R000037226
Scientific Title Development and Evaluation of Birth and Parenting Planning Program for Women Who Have Been Diagnosed With Fetal Anomalies
Date of disclosure of the study information 2018/10/01
Last modified on 2022/02/14 21:48:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development and Evaluation of Birth and Parenting Planning Program for Women Who Have Been Diagnosed With Fetal Anomalies

Acronym

Development and Evaluation of Birth and Parenting Planning Program for Women Who Have Been Diagnosed With Fetal Anomalies

Scientific Title

Development and Evaluation of Birth and Parenting Planning Program for Women Who Have Been Diagnosed With Fetal Anomalies

Scientific Title:Acronym

Development and Evaluation of Birth and Parenting Planning Program for Women Who Have Been Diagnosed With Fetal Anomalies

Region

Japan


Condition

Condition

Women who have been diagnosed with fetal anomalies

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop Birth and Parenting Planning (BPPing) program for women who have been diagnosed with fetal anomalies.

Basic objectives2

Others

Basic objectives -Others

To evaluate BPPing program.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ratio of women who submit a written preference paper called BP/BPP

Key secondary outcomes

Quality data on the description of BP/BPP and questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

BPPing Program for women who have been diagnosed with fetal anomalies/Usual care

Interventions/Control_2

Intervention group has more than two meetings with team midwife in pregnancy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

A pregnant woman who have been diagnosed with fetal anomalies, who is 20 years old or older after 22 weeks of pregnancy, who can communicate, read and write in Japanese, and to visit to a research facility as a outpatient not maternal transport.

Key exclusion criteria

Women who have taken psychiatry or psychosomatic medicine.
Women who have been diagnosed with Intrauterine fetal death at fist time visiting to research facility.
Women who require hospital care in pregnancy by pregnancy complication before onset.
Women who are considered in appropriate to participate by obstetrician.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Maki
Middle name
Last name Kitazono

Organization

Kanagawa Children's Medical Center

Division name

Nursing Department

Zip code

2328555

Address

2-138-4 Mutukawa-Cho Minami-ku Yokohama

TEL

0457112351

Email

16dn007@slcn.ac.jp


Public contact

Name of contact person

1st name Maki
Middle name
Last name Kitazono

Organization

Kanagawa Children's Medical Center

Division name

Ethics Commitee in general affairs department

Zip code

2328555

Address

2-138-4 Mutukawa-Cho Minami-ku Yokohama

TEL

0457112351

Homepage URL


Email

16dn007@slcn.ac.jp


Sponsor or person

Institute

St.Luke's International University

Institute

Department

Personal name



Funding Source

Organization

Japan Academy of Midwife

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

St.Luke's International University

Address

10-1 Akashi-cho Tyu-o-ku Tokyo

Tel

03-3543-6391

Email

kenkyukikaku@luke.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神奈川県立こども医療センター(神奈川県)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 01 Day


Related information

URL releasing protocol

Not yet officially announced

Publication of results

Unpublished


Result

URL related to results and publications

https://luke.repo.nii.ac.jp/?action=pages_view_main&active_action=repository_view_main_item_detail&i

Number of participants that the trial has enrolled

61

Results

The intervention group had a significantly higher rate submitting BP/BPP (96.0%vs.7.1%, p<0.001) and significantly higher SRESP (t=3.210, p=0.003). The intervention group tended to have higher but non-significant Satisfaction of Care scores. The J-SSQ had no significant differences between the two groups. Women's preferences were both similar and unique. The intervention group had more positive statements (BP/BPP) about their experience.

Results date posted

2022 Year 02 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Average age: 33.5 years old
The baby's fetal diagnosis: congenital heart disease (n=18), craniofacial disease (n=9), neural tube defects (n=4), congenital diaphragmatic hernias (n=4),chromosomal abnormalities (n=3), Gastrointestinal closure (n=3), and others (n=10).

Participant flow

Sixty-two women (32 in the intervention group, 30 in the control group) were enrolled, 11 women were dropped out during the intervention period (7 in the intervention group; 21.9%, 4 in the control group; 13.3%). Fifty-five women were analyzed.

Adverse events

There was no adverse event.

Outcome measures

Primary outcome
The rate submitting BP/BPP

Secondary outcome
1)Quantitative data
The Score of Women's perception of being able to express and sharing of hopes scale
The Score of Social support scale
The Score of Women's Care Satisfaction Scale and VAS for satisfaction

2)Qualitative data
The contents described women's BP/BPP
Descriptions of Women's perception of being able to express and sharing of hopes
Descriptions women's perception of care

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 20 Day

Date of IRB

2018 Year 09 Month 19 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2019 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 03 Month 01 Day

Date analysis concluded

2020 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2018 Year 08 Month 03 Day

Last modified on

2022 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name